Graham Holdings Company (GHC) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
13 Oct, 2025Executive summary
Net income attributable to common shares was $23.9 million ($5.45 per share) for Q1 2025, down from $124.4 million ($27.72 per share) in Q1 2024, mainly due to lower gains on marketable equity securities and higher interest expense from mandatorily redeemable noncontrolling interest adjustments.
Revenue increased 1% year-over-year to $1,165.9 million, with growth in education, healthcare, and other businesses, offset by declines in television broadcasting, manufacturing, and automotive.
Operating income rose to $47.5 million from $35.4 million, a 34% increase, driven by improvements in education, manufacturing, and healthcare.
Adjusted net income (non-GAAP) was $51.0 million ($11.64 per share), nearly flat year-over-year.
Financial highlights
Q1 2025 revenue: $1,165.9 million (up 1% year-over-year).
Net income attributable to common stockholders: $23.9 million, down from $124.4 million in Q1 2024.
Operating income: $47.5 million, up from $35.4 million.
Diluted EPS: $5.45, compared to $27.72 in Q1 2024.
Net gains on marketable equity securities: $43.8 million (Q1 2024: $104.2 million).
Adjusted operating cash flow (non-GAAP) increased 6% to $88.0 million.
Capital expenditures were $14.1 million, down from $21.5 million in Q1 2024.
Cash, marketable equity securities, and other investments totaled $1,114.7 million at quarter-end.
Outlook and guidance
Management expects sufficient financial resources for the next 12 months, including working capital, capital expenditures, interest, acquisitions, dividends, and stock repurchases.
Capital expenditures for 2025 are estimated at $85–$95 million.
Dividend expected at $7.20 per share for 2025.
Latest events from Graham Holdings Company
- Shareholders to vote on three director nominees at the in-person annual meeting.GHC
Proxy filing24 Mar 2026 - Proxy details director elections, executive pay, risk oversight, and controlled company governance.GHC
Proxy filing24 Mar 2026 - 2025 revenue rose 3%, but net income dropped 60% due to prior-year pension gains.GHC
Q4 202525 Feb 2026 - Strong 2024 results, unanimous director approval, and strategic growth amid tariff and market risks.GHC
AGM 20253 Feb 2026 - Disciplined capital allocation and growth in education, healthcare, and media drive strong results.GHC
Investor Day 202411 Jan 2026 - Strong organic growth, disciplined capital allocation, and AI adoption drive robust 2025 results.GHC
Investor Day 202511 Dec 2025 - Director elections and executive pay vote highlight a governance-focused annual meeting.GHC
Proxy Filing2 Dec 2025 - Annual meeting to elect three directors, with online voting and sustainability options.GHC
Proxy Filing2 Dec 2025 - Q3 net income and EPS surged on equity gains and segment growth, but operating income declined.GHC
Q3 202529 Oct 2025